• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ZIVO Bioscience, Inc.

ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses
September 10, 2025
From ZIVO Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO’s Immune-Enhancing Compounds in Poultry
June 20, 2025
From ZIVO Bioscience, Inc.
Via Business Wire
Tickers ZIVO
University of Delaware Study Identifies Optimal Formulation of ZIVO’s Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry
May 06, 2025
From ZIVO Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry
February 06, 2025
From ZIVO Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience to Present at The Microcap Conference 2025
January 22, 2025
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities
December 23, 2024
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza
December 20, 2024
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens
August 23, 2024
From ZIVO Bioscience, Inc.
Via Business Wire
Tickers ZIVO
Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience’s Coccidiosis Treatment in Broiler Chickens
July 08, 2024
From ZIVO Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study
February 07, 2024
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience Announces Uplisting to OTCQB Market
January 29, 2024
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
January 23, 2024
From Zivo Bioscience, Inc.
Via Business Wire
Tickers OTC ZIVO
ZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens
October 30, 2023
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience Announces Reverse Stock Split
October 26, 2023
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience to Present at the Dawson James Small Cap Growth Conference
October 03, 2023
From Zivo Bioscience, Inc.
Via GlobeNewswire
Tickers ZIVO ZIVOW
Trial Results Confirm Efficacy of ZIVO Bioscience’s Non-Antibiotic Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
September 19, 2023
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Announces Commitment by ZWorldwide to Purchase all Zivolife™ Algal Biomass Product Produced Over the Next 18 Months
August 16, 2023
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Commences Sales of its Proprietary Algal Biomass as Human Food
July 26, 2023
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience Announces Pricing of $4.0 Million Registered Direct Offering Priced At-The-Market
June 30, 2023
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO’s GRAS Designation Reaffirmed for Proprietary Algal Biomass Product as a Human Food Ingredient
May 30, 2023
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience Receives $1 Million Bridge Financing
April 05, 2023
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience Announces Results of Study with its Product Candidate for the Prevention and Treatment of Coccidiosis in Broiler Chickens
February 10, 2023
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience Announces Plans for a New Streamlined, Focused Corporate Structure and Establishes the ZIVOLife Agtech Business
October 24, 2022
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience CEO Issues Letter to Shareholders
September 23, 2022
From Zivo Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Reports that USDA Claims Regulatory Jurisdiction for New Coccidiosis Treatment
August 10, 2022
From ZIVO Bioscience, Inc.
Via Business Wire
Tickers ZIVO
Zivo Bioscience Joins Russell Microcap® Index
June 27, 2022
From ZIVO Bioscience, Inc.
Via Business Wire
Tickers ZIVO
Zivo Bioscience Regains Compliance Following Receipt of Noncompliance Notice from Nasdaq
April 25, 2022
From ZIVO Bioscience, Inc.
Via Business Wire
Tickers ZIVO
ZIVO Bioscience Names Chairman John B. Payne as President and CEO
January 10, 2022
From ZIVO Bioscience, Inc.
Via Business Wire
Tickers ZIVO
Recent Quotes
View More
Symbol Price Change (%)
GOOG  245.22
+0.58 (0.24%)
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap